Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (BSX)
NYSE:BSX
BSX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$77.29 - $108.94
Previous CloseN/A
Volume5.49M
Average Volume (3M)6.80M
Market Cap
$154.32B
Enterprise Value$172.04B
Total Cash (Recent Filing)$725.00M
Total Debt (Recent Filing)$11.71B
Price to Earnings (P/E)62.0
Beta0.81
Next Earnings
Oct 22, 2025EPS Estimate
0.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.75
Shares Outstanding1,481,751,600
10 Day Avg. Volume5,857,342
30 Day Avg. Volume6,795,180
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.11
Enterprise Value/Revenue9.80
Enterprise Value/Gross Profit15.85
Enterprise Value/Ebitda41.37
Forecast
1Y Price Target
$125.08Price Target Upside20.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering24
Bulls Say, Bears Say
Bulls Say
EarningsBoston Scientific reported Q2 revenue and EPS ahead of expectations due to strong performance in PFA and Watchman products.
Growth OutlookBSX raised its 2025 organic growth guidance to 14-15%, which is higher than previous estimates.
Product InnovationThe label expansion for Watchman to include the option to use Intracardiac Echocardiography (ICE) can materially speed up the procedure as it removes the need for general anesthesia.
Bears Say
Product AdvisoryBoston Scientific issued a physician advisory letter highlighting calcification risk in older-generation ePTFE-coated ENDOTAK RELIANCE defibrillation leads.
Product DiscontinuationManagement anticipates an impact on Interventional Cardiology due to the neo2 discontinuation.
Sales ImpactThe adjusted income statement had a $100m impact in Q2 with the majority of this being inventory charges and the rest being sales returns.
Boston Scientific News
BSX FAQ
What was Boston Scientific’s price range in the past 12 months?
Boston Scientific lowest stock price was $77.29 and its highest was $108.94 in the past 12 months.
What is Boston Scientific’s market cap?
Boston Scientific’s market cap is $154.32B.
When is Boston Scientific’s upcoming earnings report date?
Boston Scientific’s upcoming earnings report date is Oct 22, 2025 which is in 67 days.
How were Boston Scientific’s earnings last quarter?
Boston Scientific released its earnings results on Jul 23, 2025. The company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.725 by $0.025.
Is Boston Scientific overvalued?
According to Wall Street analysts Boston Scientific’s price is currently Undervalued.
Does Boston Scientific pay dividends?
Boston Scientific does not currently pay dividends.
What is Boston Scientific’s EPS estimate?
Boston Scientific’s EPS estimate is 0.72.
How many shares outstanding does Boston Scientific have?
Boston Scientific has 1,481,751,600 shares outstanding.
What happened to Boston Scientific’s price movement after its last earnings report?
Boston Scientific reported an EPS of $0.75 in its last earnings report, beating expectations of $0.725. Following the earnings report the stock price went up 4.459%.
Which hedge fund is a major shareholder of Boston Scientific?
Currently, no hedge funds are holding shares in BSX
Boston Scientific Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$125.08 (20.10% Upside)
$125.08 (20.10% Upside)
Blogger Sentiment
Bullish
BSX Sentiment 76%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 622.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.4%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.28%
12-Months-Change
Fundamentals
Return on Equity
11.71%
Trailing 12-Months
Asset Growth
11.99%
Trailing 12-Months
Company Description
Boston Scientific
Boston Scientific Corporation is a global medical technology company that develops, manufactures, and markets a wide range of medical devices. Founded in 1979 and headquartered in Marlborough, Massachusetts, the company operates in various sectors including cardiovascular, rhythm management, endoscopy, urology, and neuromodulation. Boston Scientific's core products include stents, catheters, pacemakers, and other innovative devices designed to improve patient outcomes and enhance the quality of life.
BSX Company Deck
BSX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, particularly in the Cardiovascular and Electrophysiology segments, with significant contributions from geographic expansion and product line success. However, challenges such as the discontinuation of the ACURATE valve and slow growth in certain regions were noted.View all BSX earnings summariesBSX Revenue Breakdown
64.22% Cardiovascular
35.79% MedSurg
BSX Stock 12 Month Forecast
Average Price Target
$125.08
▲(20.10% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
28.68% Mutual Funds
15.35% Other Institutional Investors
34.55% Public Companies and Individual Investors